Golden State Equity Partners Pfizer Inc Transaction History

Golden State Equity Partners

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $381,680 - $495,761	14,607 Added 134.18%	25,493 $733,000
Q3 2023 Oct 20, 2023	BUY	$32.09 - $37.51 $5,647 - $6,601	176 Added 1.64%	10,886 $361,000
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $175,434 - $202,974	-4,857 Reduced 31.2%	10,710 $392,000
Q1 2023 Jun 01, 2023	BUY	$39.39 - $51.28 $411,192 - $535,311	10,439 Added 203.57%	15,567 $635 Million
Q1 2022 May 18, 2022	SELL	$45.75 - $56.69 $43,279 - $53,628	-946 Reduced 15.57%	5,128 $265,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $611,494 - $757,718	-13,366 Reduced 68.76%	6,074 $220,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $18,841 - $27,930	456 Added 2.4%	19,440 $1.15 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $387,397 - $497,645	9,870 Added 108.29%	18,984 $817,000
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $109,166 - $123,667	3,040 Added 50.05%	9,114 $357,000
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $15,673 - $17,676	-468 Reduced 7.15%	6,074 $220,000
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $218,960 - $278,427	6,542 New	6,542 $240,000

3,222

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

Stay updated on Golden State Equity Partners with notifications on news.